Omeros Corporation
COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION
Last updated:
Abstract:
The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation.
Status:
Application
Type:
Utility
Filling date:
24 Apr 2020
Issue date:
25 Feb 2021